9月12日，深圳大學(xué)附屬華南醫(yī)院泌尿外科學(xué)科帶頭人吳松教授帶領(lǐng)團(tuán)隊(duì)，與德國夏洛特大學(xué)綜合醫(yī)院泌尿外科主任、歐洲泌尿外科領(lǐng)域領(lǐng)軍人物Schlomm教授，舉行了一場高水平的中德線上學(xué)術(shù)交流。會議由深圳大學(xué)附屬華南醫(yī)院泌尿外科主任侯騰主持，吳松教授致歡迎辭，為雙方的深入對話拉開了序幕。在隨后的介紹環(huán)節(jié)，涂門江博士詳細(xì)匯報了深圳大學(xué)附屬華南醫(yī)院泌尿外科的臨床與科研成果。作為一個成立僅三年的年輕科室，該團(tuán)隊(duì)?wèi){借快速發(fā)展和扎實(shí)成績，已經(jīng)展現(xiàn)出與國際接軌的實(shí)力。Schlomm教授對這一成就表示高度贊賞，并指出雙方團(tuán)隊(duì)在泌尿系統(tǒng)腫瘤、基因組學(xué)研究以及人工智能在醫(yī)學(xué)中的應(yīng)用等方面有著天然的契合點(diǎn)。作為歐洲泌尿外科的權(quán)威專家，Schlomm教授以“夏洛特—深圳對話：通過科研與臨床經(jīng)驗(yàn)共享推動泌尿外科發(fā)展”為主題，帶來了系統(tǒng)而深刻的分享。在臨床方面，他重點(diǎn)介紹了自己團(tuán)隊(duì)首創(chuàng)的全功能尿道括約肌保留前列腺癌根治術(shù)。這一術(shù)式的創(chuàng)新突破了傳統(tǒng)手術(shù)的局限，在保證腫瘤治療效果的同時，大幅提升了患者術(shù)后的尿控功能和生活質(zhì)量，被譽(yù)為改善患者生存質(zhì)量的重要里程碑。在科研層面，Schlomm教授展示了他們?nèi)绾卫萌斯ぶ悄芘c基因數(shù)據(jù)相結(jié)合，推動精準(zhǔn)醫(yī)療的發(fā)展。通過對大規(guī)模真實(shí)世界數(shù)據(jù)與分子層面數(shù)據(jù)的整合分析，他們能夠開發(fā)出動態(tài)預(yù)測算法，不僅幫助醫(yī)生更好地為患者制定個性化治療方案，也為理解疾病發(fā)展和耐藥機(jī)制提供了新思路。這些探索正在逐漸改變泌尿外科的診療模式，讓醫(yī)學(xué)從“經(jīng)驗(yàn)驅(qū)動”走向“數(shù)據(jù)驅(qū)動”。會議氣氛熱烈而真誠，雙方在分享經(jīng)驗(yàn)與交流思路中找到了諸多共鳴。未來，中德雙方將繼續(xù)攜手合作，不僅在臨床診療技術(shù)上互學(xué)互鑒，更在科研創(chuàng)新上深度融合，共同探索泌尿外科的前沿方向。這場跨越國界的對話，不僅是一場學(xué)術(shù)盛宴，更是合作新征程的起點(diǎn)。

On September 12th, Prof. WU Song, the academic leader of the Department of Urology at South China Hospital of Shenzhen University, together with his team, had a high-level Sino-German online academic exchange with Prof. Schlomm, Director of the Department of Urology at the Charité - Universit?tsmedizin Berlin in Germany. The meeting was hosted by HOU Teng, Director of the Department of Urology at South China Hospital of Shenzhen University. Prof. WU Song delivered a welcome speech for the meeting, setting the stage for in-depth dialogue between the two parties. In the subsequent introduction session, Dr. TU Menjiang gave a detailed report on the clinical and research achievements of the Department of Urology at South China Hospital of Shenzhen University. As a young department established only three years ago, the team has demonstrated internationally advanced capabilities through its rapid development and solid accomplishments. Prof. Schlomm expressed high appreciation for these achievements and pointed out that the teams of both parties have natural match in areas such as urological oncology, genomics research, and the application of artificial intelligence in medicine. As a key figure in urology in Europe, Prof. Schlomm delivered a systematic and insightful presentation entitled "Charité-Shenzhen Dialogue: Advancing Urology through Sharing Research and Clinical Experience". In terms of clinical practice, he focused on introducing his team's technique of Full Functional-Length Urethral Sphincter Preservation During Radical Prostatectomy. This innovative surgical method breaks through the limitations of conventional operations, significantly improving patients' postoperative urinary control and quality of life while ensuring effective tumor treatment, and is hailed as an important milestone in enhancing patients' quality of life. Scientifically, Prof. Schlomm demonstrated how they are promoting the development of precision medicine by combining artificial intelligence with genetic data. Through integrated analysis of large-scale real-world data and molecular-level data, they have been able to develop dynamic prediction algorithms that not only help doctors better formulate personalized treatment plans for patients but also provide new insights into understanding disease progression and drug resistance mechanisms. These explorations are gradually changing the diagnosis and treatment model in urology, transforming medicine from "experience-driven" to "data-driven". The meeting was characterized by a warm and sincere atmosphere, with both parties finding much common ground in sharing experiences and exchanging ideas. In the future, the Chinese and German teams both will continue their cooperation, not only learning from each other in clinical diagnosis and treatment but also deeply integrating in scientific research innovation to jointly explore cutting-edge directions in urology. This cross-border dialogue is not only an academic feast but also the starting point of a new journey of cooperation.